Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind…

Overview of attention for article published in BMC Medical Genomics, October 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets

patent: 1 patent

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 106 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Is a ketogenic diet effective against dementia?

Sign of the Times, 29 May 2021

© Sebastian Rushworth.com A sea change is underway. Ten years ago, it was heresy to propose that a ketogenic (a.k.a low carb…

Genetic Profile Identified for Alzheimer's Patients Showing Heightened Response to Accera's Breakthrough Product Axona®

Bioportfolio, 30 Sep 2017

BROOMFIELD, Colo., Oct. 17, 2011 /PRNewswire/ -- Accera, Inc., a biotech company specializing in cognitive health, announced…